- cafead   Apr 26, 2020 at 02:02: PM
via Sanofi anticipates study results for an arthritis drug repurposed to treat COVID-19 will be available "imminently," said Paul Hudson, CEO of the French drugmaker, which along with Regeneron is testing the immune-blocking therapy Kevzara in two clinical trials.
article source
article source